Yulei Wang

27.7k citations

82 papers · 10.6k indexed · 7 hit papers · h-index 34

Impact in

Cancer Research top 0.1%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Molecular Biology top 0.5%
- RNA modifications and cancer
- RNA Research and Splicing
- Circular RNAs in diseases
- RNA and protein synthesis mechanisms
- Epigenetics and DNA Methylation

Papers in

Cancer Research 24
- MicroRNA in disease regulation 12
- Cancer-related molecular mechanisms research 9
- Cancer Genomics and Diagnostics 6
Oncology 24
- Cancer Immunotherapy and Biomarkers 12

Co-authors: Tiffany Hung Rui Li Robert B. West Marc J. van de Vijver Miao-Chih Tsai Howard Y. Chang Pedram ArganiKe Wang
Journals: Journal of Clinical Oncology (5 papers)PLoS ONE (4 papers)Nature Communications (3 papers)Proceedings of the National Academy of Sciences (3 papers)Poultry Science (2 papers)
Partner nations: United States China France

In The Last Decade

Yulei Wang

77 papers receiving 10.4k citations

Hit Papers

7 papers align trajectories log scale

Tiragolumab in combination with atezolizumab and bevacizumab in patients with unresectable, locally advanced or metastatic hepatocellular carcinoma (MORPHEUS-Liver): a randomised, open-label, phase 1b–2, study 2025 · 26 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2025 The Lancet Oncology
2022 Nature Medicine
2021 Cancer Cell
2012 Nature
2010 Nature
2003 Proceedings of the National Academy of Sciences
2002 Proceedings of the National Academy of Sciences

Peers

Countries citing papers authored by Yulei Wang

Since Specialization

Citations

This map shows the geographic impact of Yulei Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yulei Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yulei Wang more than expected).

Fields of papers citing papers by Yulei Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yulei Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yulei Wang. The network helps show where Yulei Wang may publish in the future.

Co-authors

The 25 scholars most cited alongside Yulei Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yulei Wang Line = papers co-authored together Yulei Wang links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Dietary supplementation of coffee pulp extract enhances growth performance and intestinal morphology in broiler chicken Poultry Science ·Kirti Rami, Chompunut Lumsangkul, Chaiwat Arjin, Sasithorn Sirilun, G. I. Mihalyov, Yulei Wang, 周世康, Chen‐Si Lin, Sarana Rose Sommano, Korawan Sringarm	2025	3
2	Computational studies reveal structural characterization and novel families of Puccinia striiformis f. sp. tritici effectors PLoS Computational Biology ·大金美和, Nan Wu, Olga Borkivska, Yulei Wang, Mahinur S. Akkaya	2025	1
3	Targeting tumor-intrinsic BCL9 reverses immunotherapy resistance by eliciting macrophage-mediated phagocytosis and antigen presentation Nature Communications ·Suiyi Wu, Yuanyuan Zhu, Jialei Sun, Chunyan Wang, Yulei Wang, Xiaolin Qian, Fei Song, Xun Huang, Sangodele A.O., Yeou Wei Yang, Lian Shen, Yang Xu, Cheng Huang, Jiang Xiao-ting, Jian Zhou, Andrew X. Zhu, Jia Fan, Di Zhu, Bo Hu, Xin‐Rong Yang	2025	1
4	1853MO Efficacy and safety of rilvegostomig, an anti-PD-1/TIGIT bispecific antibody, for checkpoint inhibitor (CPI)-naïve metastatic non-small cell lung cancer (mNSCLC): ARTEMIDE-01 Annals of Oncology ·Byoung Chul Cho, J.T.J.N. Hiltermann, Hiroki Izumi, Mariana Brandão, 野竹宏彰, Pongwut Danchaivijitr, Enriqueta Felip, Gwo Fuang Ho, Ravi Bapat, Yongsheng Li, Na Shen, Michael Shindler, Els Wauters, COLONEL PAUL GALLAGHER, Tatsuya Yoshida, Shao han Yin, Ikbel Achour, Nathaphon Boonnam, 陸普莎, Yulei Wang	2025	0
5	Non-small cell lung cancer molecular subtypes and vulnerability to immunotherapy treatment combinations Nature Communications ·Tianshi Lu, Habib Hamidi, Mark A. Socinski, Martin Reck, Federico Cappuzzo, Fabrice Barlési, Robert M. Jotte, Sören Müller, Aditi Qamra, Assaf Amitai, Xiangnan Guan, Yexinghan Hu, Hartmut Koeppen, Jennifer M. Giltnane, David S. Shames, Charlotta Nelsson, Meng He, Yulei Wang, Minu K. Srivastava, Barzin Y. Nabet	2025	0
6	Development of mutated β-catenin gene signature to identify CTNNB1 mutations from whole and spatial transcriptomic data in patients with HCC JHEP Reports ·Brandon M. Lehrich, Junyan Tao, Silvia Liu, Théo Z. Hirsch, Tyler M. Yasaka, Yongmei Huang, Evan R. Delgado, Xiangnan Guan, Shan Lu, Bárbara Soares Machado, Rina Huamanrayme Bustamante, Sucha Singh, Minakshi Poddar, Aaron Bell, Aatur D. Singhi, Jessica Zucman‐Rossi, Yulei Wang, Satdarshan P. Monga	2024	11
7	Laser-induced damages to charge coupled devices with combined nanosecond/picosecond short-pulse lasers Frontiers in Physics ·光大場, Clede, Hao Chang, Yunfei Li, 卓若木, Yu Yu, Gong Wang, Ziqi Tang, Lifang Li, Yulei Wang, Zhiwei Lü	2024	0
8	Risk of interstitial lung disease with the use of programmed cell death 1 (PD-1) inhibitor compared with programmed cell death ligand 1 (PD-L1) inhibitor in patients with breast cancer: A systematic review and meta-analysis SHILAP Revista de lepidopterología ·Lijuan Guo, Xiaoyi Lin, 治江村山, Yulei Wang, Jiali Lin, Yi Zhang, Xiangqing Chen, Miao Chen, Guochun Zhang, Zhang Yi-fang	2023	1
9	Integrated digital pathology and transcriptome analysis identifies molecular mediators of T-cell exclusion in ovarian cancer Nature Communications ·Mélanie Desbois, Akshata R. Udyavar, Lisa Ryner, Cleopatra Kozlowski, Yinghui Guan, Milena Dürrbaum, Shan Lu, Jean‐Philippe Fortin, Hartmut Koeppen, James Ziai, Ching‐Wei Chang, Shilpa Keerthivasan, Marie Plante, Richard Bourgon, Carlos Bais, Priti S. Hegde, Anneleen Daemen, Shannon J. Turley, Yulei Wang	2020	139
10	The serum proteomics tracking of hepatocellular carcinoma early recurrence following radical resection SHILAP Revista de lepidopterología ·Hu Liu, Hexin Chen, Mehdi Maleki, Ying Sun, Yulei Wang, Yong Zeng, Gang Chen, Xiyong Liu, Xiaojing Xing, Bin Zhao, Jia Liu	2019	3
11	MicroRNA-127-3p controls murine hematopoietic stem cell maintenance by limiting differentiation Haematologica ·Laura Crisafulli, Sharon Muggeo, Paolo Uva, Yulei Wang, Masayuki Iwasaki, Silvia L. Locatelli, Achille Anselmo, Federico Colombo, Carmelo Carlo‐Stella, Michael L. Cleary, Anna Villa, Bernhard Gentner, Francesca Ficara	2019	14
12	High-Throughput and Sensitive Quantification of Circulating Tumor DNA by Microfluidic-Based Multiplex PCR and Next-Generation Sequencing Journal of Molecular Diagnostics ·Yinghui Guan, Oleg Mayba, Thomas Sandmann, Shan Lu, YounJeong Choi, Walter C. Darbonne, Vincent Lévêque, Lisa Ryner, Eric W. Humke, Selvi Rajan, Vojtěch Chmil, Anna Cheung, Richard Bourgon, Mark R. Lackner, Yulei Wang	2017	18
13	Development and application of a general plasmid reference material for GMO screening Plasmid ·Yuhua Wu, Jun Li, Yulei Wang, Xiaofei Li, Yunjing Li, Li Zhu, Gang Wu	2016	9
14	Upregulation of Periostin and Reactive Stroma Is Associated with Primary Chemoresistance and Predicts Clinical Outcomes in Epithelial Ovarian Cancer Clinical Cancer Research ·Lisa Ryner, Yinghui Guan, Ron Firestein, Yuanyuan Xiao, Bharmal Choudhary, Christina Rabe, Shan Lu, Yexinghan Hu, Ling‐Yuh Huw, Mark R. Lackner, Ling Fu, Lukas C. Amler, Carlos Bais, Yulei Wang	2015	86
15	High-Throughput Detection of Clinically Relevant Mutations in Archived Tumor Samples by Multiplexed PCR and Next-Generation Sequencing Clinical Cancer Research ·Richard Bourgon, Shan Lu, Yibing Yan, Mark R. Lackner, Weiru Wang, Victor Weigman, David Wang, Yinghui Guan, Lisa Ryner, Hartmut Koeppen, Rajesh Patel, Garret M. Hampton, Lukas C. Amler, Yulei Wang	2014	52
16	Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis Nature ·Rajnish A. Gupta, Nilay Shah, Ke Wang, Jeewon Kim, Hugo M. Horlings, David J. Wong, Miao-Chih Tsai, Tiffany Hung, Pedram Argani, John L. Rinn, Yulei Wang, Pius Brzoska, Zhai Kui, Rui Li, Robert B. West, Marc J. van de Vijver, Saraswati Sukumar, Howard Y. Chang Hit paper breakdown →	2010	4231
17	The Genomic Analysis of Erythrocyte microRNA Expression in Sickle Cell Diseases PLoS ONE ·Shaoyin Chen, Yulei Wang, Marilyn J. Telen, Jen‐Tsan Chi	2008	157
18	Gene expression profiling of substantia nigra dopamine neurons: further insights into Parkinson's disease pathology Brain ·Filip Šimunović, Ming Yi, Yulei Wang, Maria Nühlen, Lauren T. Brown, Anna M. Krichevsky, Susan L. Andersen, Robert M. Stephens, Francine M. Beneš, Kai‐Christian Sonntag	2008	289
19	Long versus short oligonucleotide microarrays for the study of gene expression in nonhuman primates Journal of Neuroscience Methods ·Stephen J. Walker, Yulei Wang, Xiyue He, Frances Chan, Gary M. Hellmann	2005	33
20	Genome-wide analysis of mRNA translation profiles in Saccharomyces cerevisiae Proceedings of the National Academy of Sciences ·Yoav Arava, Yulei Wang, John D. Storey, Chih Long Liu, Patrick O. Brown, Daniel Herschlag Hit paper breakdown →	2003	535

About Yulei Wang

Yulei Wang is a scholar working on Cancer Research, Oncology, Hepatology, Molecular Biology and Reproductive Medicine, having authored 82 papers that have together received 10.6k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (12 papers), Cancer Immunotherapy and Biomarkers (12 papers), Cancer-related molecular mechanisms research (9 papers), Molecular Biology Techniques and Applications (7 papers), Ferroptosis and cancer prognosis (6 papers), Cancer Genomics and Diagnostics (6 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers) and RNA Research and Splicing (6 papers). The work is most often cited by research in Cancer Research (5.5k citations), Molecular Biology (7.7k citations), Oncology (1.9k citations), Hepatology (469 citations) and Immunology (893 citations). Yulei Wang has collaborated with scholars based in United States, China and France. Frequent co-authors include Tiffany Hung, Rui Li, Robert B. West, Marc J. van de Vijver, Miao-Chih Tsai, Howard Y. Chang, Pedram Argani, Ke Wang, Nilay Shah and Hugo M. Horlings. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE, Nature Communications, Proceedings of the National Academy of Sciences and Poultry Science.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact